Results 241 to 250 of about 314,954 (325)

Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study

Liver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background/Aims Immune checkpoint inhibitors (ICIs) have transformed advanced HCC treatment. The benefit of sequential immunotherapy after prior ICI failure remains unclear. Given the expanded use of atezolizumab plus bevacizumab (Ate/Bev) over the past 5 years, we explored the real‐world outcomes of nivolumab plus ipilimumab (Nivo/Ipi) in ...
Jung Sun Kim, Jeffrey Wong, San‐Chi Chen, David Tai, Hannah Yang, Youngun Kim, Beodeul Kang, Ilhwan Kim, Hyeyeong Kim, Chansik An, Su Jin Jang, Masatoshi Kudo, Ho Yeong Lim, Chan Kim, Thomas Yau, Hong Jae Chon   +15 more
wiley   +1 more source

Acral lentiginous melanoma demonstrates more aggressive pathological features than non-acral melanoma in Jamaica: A 10-year multicenter study. [PDF]

JAAD Int
Collie CJ, Jean-Marie SL, Thompson RK, Williams NP, Ho JD.   +4 more
europepmc   +1 more source

Principles for Optimal Drug Selection in IgA Nephropathy—Time for Integrating Pathogenesis and Clinical Markers to Guide Therapy

Nephrology, Volume 31, Issue 2, February 2026.
ABSTRACT IgA nephropathy is a progressive glomerular disease with a variable clinical course and a substantial risk of progression to end‐stage kidney failure. While proteinuria has long been the central therapeutic target, insights into disease pathogenesis indicate that haematuria should also guide treatment decisions. Based on the pathophysiology of
Yusuke Suzuki
wiley   +1 more source

Myriad Pathways to Universality: How Widely Sourced Data, Use of Frameworks and Innovative Analytic Methods Help Tackle Immunization Inequality. [PDF]

Vaccines (Basel)
Nambiar D, Hosseinpoor AR, Bergen N, Danovaro-Holliday MC, Dadari I, Johnson HL.   +5 more
europepmc   +1 more source

Orexin Receptor Antagonism Improves Sleep Quality and Mitigates Lipopolysaccharide‐Induced Inflammatory Responses in a Mouse Model

The FASEB Journal, Volume 40, Issue 1, 15 January 2026.
Inhibiting orexin improves sleep quality and mitigates inflammation of LPS‐induced mice. ABSTRACT Alterations in the immune system, stemming from sleep/wakefulness disorders, increase the risk of inflammatory pathologies. Orexin, a hypothalamic neuropeptide, regulates sleep and wakefulness.
Dai Horiuchi, Yoko Irukayama‐Tomobe, Jun‐Dal Kim, Yoshitoshi Kasuya, Tsuyoshi Nemoto, Takuji Suzuki, Yoshimi Nakagawa, Koichiro Tatsumi   +7 more
wiley   +1 more source

Diagnosis of a Perforated Small Bowel Diverticulum in an Elderly Patient Hindered by a Nuck Cyst: A Case Report. [PDF]

Cureus
Leal Isla Flores V, Nava Palomo CL, Guerra Bocanegra ER, Rabago Jamaica AP, Moreno Juárez JH.   +4 more
europepmc   +1 more source

Multiscale drought dataset for the Greater Antilles: a resource for environmental and adaptation studies. [PDF]

Sci Data
Stojanovic M, Sorí R, Pérez-Alarcón A, Nieto R, Gimeno L.   +4 more
europepmc   +1 more source

The impact of multiple infections and community knowledge on engagement with a historical deworming programme: hookworm and Ascaris in Jamaica, 1913-1936. [PDF]

Trans R Soc Trop Med Hyg
Roberts JD, Waddington LL, Quinnell RJ, Dunn AM.   +3 more
europepmc   +1 more source

From the heart to the kidney: A case report of Wunderlich syndrome following structural valve intervention. [PDF]

Radiol Case Rep
Coutinho HMR, da Silva JA, Peralta D, Bottino R, Demier B, Brandão M, Alencar ZS, Coutinho JH, Kikuta G.   +8 more
europepmc   +1 more source